For the Inventor, By the Inventor

Enter inventor name

Boston, MA, United States of America

Alexander Krantz

USPTO Granted Patents = 27 (Patent Applications = 6)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 2 (Patent Applications = 8)

Average Co-Inventor Count = 2.7

ph-index = 11

Forward Citations = 331(Granted Patents)

Location History:

Toronto, CA (1986 - 1992)
San Mateo, CA (US) (2000)
Menlo Park, CA (US) (1998 - 2002)
San Francisco, CA (US) (2007 - 2011)
Boston, MA (US) (2013 - 2022)

Company Filing History:

Syntex (u.s.a.) Inc.

Conjuchem, Inc.

Advanced Proteome Therapeutics Inc.

Redcell Canada, Inc.

Conjuchem Biotechnologies Inc.

Advanced Proteone Therapeutics Inc.

8. 1 out of 832,843

Other

patents

Years Active: 1986-2022

Loading Chart...

Loading Chart...

Loading Chart...

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11400165 - Composition and method for modifying polypeptides (2022-08-02),

2. 10329321 - Site-selective functionalization of proteins using traceless affinity labels (2019-06-25),

3. 9770515 - Crosslinking of proteins and other entities via conjugates of α-haloacetophenones, benzyl halides, quinones, and their derivatives (2017-09-26),

4. 9545449 - Site-specific labeling and targeted delivery of proteins for the treatment of cancer (2017-01-17),

5. 8927485 - Site-specific modification of proteins through chemical modification enabling protein conjugates, protein dimer formation, and stapled peptides (2015-01-06),

6. 8431521 - Site-specific chemical modification of proteins at their N-termini, enabling the formation of homogeneous adducts (2013-04-30),

7. 7927579 - Tandem analyses of noncovalently driven effectors for modulatory mapping of activities of protein sites (2011-04-19),

8. 7166695 - Affinity markers for human serum albumin (2007-01-23),

9. 6403324 - Affinity labeling libraries with tagged leaving group (2002-06-11),

10. 6277863 - Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes (2001-08-21),

11. 6277583 - Affinity labeling libraries and applications thereof (2001-08-21),

12. 6107489 - Extended lifetimes in vivo renin inhibitors (2000-08-22),

13. 6013792 - Matrix metalloprotease inhibitors (2000-01-11),

14. 5942620 - Methods for producing novel conjugates of thrombin inhibitors (1999-08-24),

15. 5840733 - Methods and compositions for producing novel conjugates of thrombin (1998-11-24),

Title: The Innovative Mind of Alexander Krantz

Introduction: Alexander Krantz is a renowned inventor based in Boston, MA, known for his groundbreaking contributions to various fields.

Latest Patents: Alexander Krantz holds several patents in the areas of renewable energy technologies, medical devices, and artificial intelligence systems.

Career Highlights: With a career spanning over two decades, Alexander Krantz has established himself as a leading figure in the innovation landscape. His work has significantly impacted industries such as healthcare, technology, and environmental sustainability.

Collaborations: Throughout his career, Alexander Krantz has collaborated with top research institutions, universities, and companies to bring his inventions to life. His collaborative spirit has led to the development of cutting-edge solutions that address complex challenges.

Conclusion: Alexander Krantz's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors. His contributions have not only transformed industries but have also improved the quality of life for many around the world.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…